Benzimidazole analogs inhibit human herpesvirus 6

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2442-2445

  Prichard, Mark N ^a   Frederick, Samuel L ^a   Daily, Shannon ^a   Borysko, Katherine Z ^b   Townsend, Leroy B ^b   Drach, John C ^b   Kern, Earl R ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H BETA DEXTRO RIBOFURANOSYL 2 BROMO 5,6 DICHLOROBENZIMIDAZOLE; 2 BROMO 5,6 DICHLORO 1 (ALPHA LEVO 5' DEOXYLYXOFURANOSYL)BENZIMIDAZOLE; 2 BROMO 5,6 DICHLORO 1 (BETA DEXTRO ERYTHROFURANOSYL) BENZIMIDAZOLE; 2 BROMO 5,6 DICHLORO 1 BETA DEXTRO RIBOPYRANOSYL BENZIMIDAZOLE; 2 BROMO 5,6 DICHLORO 1 BETA LEVO RIBOFURANOSYL BENZIMIDAZOLE; 2 BROMO 5,6 DICHLORO 1 CARBOCYCLIC BENZIMIDAZOLE; 2 CYCLOPROPYLAMINO 5,6 DICHLORO 1 (BETA DEXTRO 5' DEOXYRIBOFURANOSYL)BENZIMIDAZOLE; 2 CYCLOPROPYLAMINO 5,6 DICHLORO 1 (BETA DEXTRO ERYTHROFURANOSYL)BENZIMIDAZOLE; 2 CYCLOPROPYLAMINO 5,6 DICHLORO 1 (BETA DEXTRO RIBOFURANOSYL)BENZIMIDAZOLE; 2 CYCLOPROPYLAMINO 5,6 DICHLORO 1 CARBOCYCLIC BENZIMIDAZOLE; 2 ISOPROPYLAMINO 5,6 DICHLORO 1 (ALPHA DEXTRO 5' DEOXYLYXOFURANOSYL)BENZIMIDAZOLE; 2 ISOPROPYLAMINO 5,6 DICHLORO 1 (ALPHA LEVO 5' DEOXYLYXOFURANOSYL)BENZIMIDAZOLE; 2 ISOPROPYLAMINO 5,6 DICHLORO 1 (BETA DEXTRO ERYTHROFURANOSYL)BENZIMIDAZOLE; BENZIMIDAVIR; BENZIMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; DRUG INHIBITION; HUMAN; HUMAN HERPESVIRUS 6; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BENZIMIDAZOLES; CYTOMEGALOVIRUS; HERPESVIRUS 6, HUMAN; HUMANS; VIRUS REPLICATION;

EID: 79955537179     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01523-10     Document Type: Article

References (29)

1. Biron, K. K., et al. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46:2365-2372.
2. Boeckh, M., V. Erard, D. Zerr, and J. Englund. 2005. Emerging viral infections after hematopoietic cell transplantation. Pediatr. Transplant. 9(suppl. 7):48-54.
3. De Bolle, L., et al. 2004. Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423. Biochem. Pharmacol. 67:325-336.
4. De Clercq, E., and L. Naesens. 2006. In search of effective anti-HHV-6 agents. J. Clin. Virol. 37(suppl. 1):S82-S86.
5. De Clercq, E., et al. 2001. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev. Med. Virol. 11:381-395.
6. Gudmundsson, K. S., et al. 2000. Synthesis and antiviral evaluation of halogenated beta-D- and -L-erythrofuranosylbenzimidazoles. J. Med. Chem. 43:2464-2472.
7. Hertel, L., S. Chou, and E. S. Mocarski. 2007. Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog. 3:e6.
8. Kern, E. R., et al. 2005. In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication. Antimicrob. Agents Chemother. 49:1039-1045.
9. Komazin, G., L. B. Townsend, and J. C. Drach. 2004. Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides. J. Virol. 78:710-715.
10. Krosky, P. M., et al. 2002. Phosphorylation of beta-D- ribosylbenzimidazoles is not required for activity against human cytomegalovirus. Antimicrob. Agents Chemother. 46:478-486.
11. Krosky, P. M., et al. 1998. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol. 72:4721-4728. (Pubitemid 28215647)
12. Kushner, N. L., et al. 2003. Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro. Nucleosides Nucleotides Nucleic Acids 22:2105-2119. (Pubitemid 37523716)
13. Ljungman, P., et al. 2007. Effectiveness of ganciclovir against human herpesvirus- 6 excreted in saliva in stem cell transplant recipients. Bone Marrow Transplant. 39:497-499. (Pubitemid 46605209)
14. Migawa, M. T., et al. 1998. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl) benzimidazoles. J. Med. Chem. 41:1242-1251.
15. Naesens, L., P. Bonnafous, H. Agut, and E. De Clercq. 2006. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. J. Clin. Virol. 37(suppl. 1):S69-S75.
16. Naesens, L., et al. 2006. Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses. Antiviral Res. 72:60-67. (Pubitemid 44291471)
17. Neyts, J., L. Naesens, C. Ying, L. De Bolle, and E. De Clercq. 2001. Antiherpesvirus activity of (1′S,2′R)-9-[[1′,2′- bis(hydroxymethyl)-cycloprop- 1′-yl]methyl] x guanine (A-5021) in vitro and in vivo. Antiviral Res. 49:115-120. (Pubitemid 32206745)
18. Prichard, M. N., W. J. Britt, S. L. Daily, C. B. Hartline, and E. R. Kern. 2005. Human cytomegalovirus UL97 kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis. J. Virol. 79:15494-15502.
19. Prichard, M. N., S. Daily, A. L. Perry, and E. R. Kern. 2008. Maribavir inhibits the replication of human herpesvirus 6 and the activity of the U69 protein kinase. Antiviral Res. 78:A29.
20. Prichard, M. N., et al. 2008. Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J. Virol. 82:5054-5067. (Pubitemid 351657065)
21. Reymen, D., et al. 1995. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res. 28:343-357.
22. Townsend, L. B., R. V. Devivar, S. R. Turk, M. R. Nassiri, and J. C. Drach. 1995. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 38:4098-4105.
23. Underwood, M. R., et al. 2004. Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus. Antimicrob. Agents Chemother. 48:1647-1651.
24. Underwood, M. R., et al. 1998. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 72:717-725. (Pubitemid 28048891)
25. Williams, S. L., et al. 2003. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses. Antimicrob. Agents Chemother. 47:2186-2192.
26. Williams-Aziz, S. L., et al. 2005. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro. Antimicrob. Agents Chemother. 49:3724-3733.
27. Yamanishi, K., et al. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067.
28. Yoshikawa, T. 2003. Human herpesvirus-6 and -7 infections in transplantation. Pediatr. Transplant. 7:11-17.
29. Zerr, D. M., et al. 2005. A population-based study of primary human herpesvirus 6 infection. N. Engl. J. Med. 352:768-776.